Animal studies have shown that inhibiting either TXNIP or NLRP3 can prevent acute kidney injury caused by rhabdomyolysis-induced ischemia-reperfusion injury (Yuan et al., 2017). The gene discussed is NLRP3; the disease is ischemia reperfusion injury.